Publication:
Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.

Simple item page
dc.conference.dateFEB 16-18, 2023
dc.conference.locationElectr Network
dc.conference.organizerGenitourinary Cancers Symposium
dc.contributor.coauthorTural, Deniz
dc.contributor.coauthorArslan, Cagatay
dc.contributor.coauthorOlmez, Omer Fatih
dc.contributor.coauthorAkar, Emre
dc.contributor.coauthorErman, Mustafa
dc.contributor.coauthorUrun, Yuksel
dc.contributor.coauthorErdem, Dilek
dc.contributor.coauthorKilickap, Saadettin
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorSelçukbiricik, Fatih
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2025-01-19T10:34:25Z
dc.date.issued2023
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.openaccessN/A
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.studentonlypublicationNo
dc.description.studentpublicationNo
dc.description.versionN/A
dc.identifier.doi10.1200/JCO.2023.41.6_suppl.481
dc.identifier.eissn1527-7755
dc.identifier.embargoN/A
dc.identifier.issn0732-183X
dc.identifier.quartileQ1
dc.identifier.urihttps://hdl.handle.net/20.500.14288/26768
dc.identifier.urihttps://doi.org/10.1200/JCO.2023.41.6_suppl.481
dc.identifier.volume41
dc.identifier.wos001098050200510
dc.keywordsObjective response rate
dc.keywordsOverall survival
dc.keywordsObjective response rate
dc.keywordsImmune checkpoint inhibitors
dc.language.isoeng
dc.publisherLippincott Williams and Wilkins
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectOncology
dc.titleComparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorSelçukbiricik, Fatih
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext